CoChat
Sign Up
Cited by 261

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia

Rampal, Raajit, Alkalin, Altuna, Madzo, Jozef, Vasanthakumar, Aparna, Pronier, Elodie, Patel, Jay, Li, Yushan, Ahn, Jihae, Abdel-Wahab, Omar, Shih, Alan, Lu, Chao, Ward, Patrick S., Tsai, Jennifer J., Hricik, Todd, Tosello, Valeria, Tallman, Jacob E., Zhao, Xinyang, Daniels, Danette, Dai, Qing, Ciminio, Luisa, Aifantis, Iannis, He, Chuan, Fuks, Francois, Tallman, Martin S., Ferrando, Adolfo, Nimer, Stephen, Paietta, Elisabeth, Thompson, Craig B., Licht, Jonathan D., Mason, Christopher E., Godley, Lucy A., Melnick, Ari, Figueroa, Maria E., Levine, Ross L.·2014·Cell Reports
DOI 10.1016/j.celrep.2014.11.004PMC PMC4267494
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2014.11.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. Abbas, 2010, Mutant Wilms’ tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD), Leukemia, 24, 660, 10.1038/leu.2009.265 · DOI
  2. Bell, 2011, DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines, Genome Biol., 12, R10, 10.1186/gb-2011-12-1-r10 · DOI · Paper page
  3. Bernt, 2011, MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L, Cancer Cell, 20, 66, 10.1016/j.ccr.2011.06.010 · DOI
  4. Bullinger, 2010, Quantitative DNA methylation predicts survival in adult acute myeloid leukemia, Blood, 115, 636, 10.1182/blood-2009-03-211003 · DOI
  5. Daigle, 2011, Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor, Cancer Cell, 20, 53, 10.1016/j.ccr.2011.06.009 · DOI
  6. Dawson, 2011, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, Nature, 478, 529, 10.1038/nature10509 · DOI
  7. Dow, 2012, A pipeline for the generation of shRNA transgenic mice, Nat. Protoc., 7, 374, 10.1038/nprot.2011.446 · DOI · Paper page
  8. Fernandez, 2009, Anthracycline dose intensification in acute myeloid leukemia, N. Engl. J. Med., 361, 1249, 10.1056/NEJMoa0904544 · DOI
  9. Figueroa, 2010, DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, 17, 13, 10.1016/j.ccr.2009.11.020 · DOI
  10. Giannopoulou, 2011, An integrated ChIP-seq analysis platform with customizable workflows, BMC Bioinformatics, 12, 277, 10.1186/1471-2105-12-277 · DOI
  11. Haber, 1991, Alternative splicing and genomic structure of the Wilms tumor gene WT1, Proc. Natl. Acad. Sci. USA, 88, 9618, 10.1073/pnas.88.21.9618 · DOI
  12. Hosen, 2007, The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis, Leukemia, 21, 1783, 10.1038/sj.leu.2404752 · DOI
  13. Kim, 2008, A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16, Neoplasia, 10, 69, 10.1593/neo.07869 · DOI
  14. Kim, 2009, An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1, Proc. Natl. Acad. Sci. USA, 106, 11154, 10.1073/pnas.0901591106 · DOI
  15. Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 · DOI · Paper page
  16. Konstandin, 2011, Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia, Leukemia, 25, 1649, 10.1038/leu.2011.134 · DOI
  17. Kulis, 2012, Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia, Nat. Genet., 44, 1236, 10.1038/ng.2443 · DOI
  18. Larsson, 1995, Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing, Cell, 81, 391, 10.1016/0092-8674(95)90392-5 · DOI
  19. Li, 2011, Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies, Blood, 118, 4509, 10.1182/blood-2010-12-325241 · DOI · Paper page
  20. Marubayashi, 2010, HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans, J. Clin. Invest., 120, 3578, 10.1172/JCI42442 · DOI
  21. Nishida, 2006, AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1, Blood, 107, 3303, 10.1182/blood-2005-04-1656 · DOI
  22. Oji, 2002, Overexpression of the Wilms’ tumor gene WT1 in de novo lung cancers, Int. J. Cancer, 100, 297, 10.1002/ijc.10476 · DOI
  23. Patel, 2012, Prognostic relevance of integrated genetic profiling in acute myeloid leukemia, N. Engl. J. Med., 366, 1079, 10.1056/NEJMoa1112304 · DOI
  24. Quivoron, 2011, TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis, Cancer Cell, 20, 25, 10.1016/j.ccr.2011.06.003 · DOI · Paper page
  25. Song, 2011, Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine, Nat. Biotechnol., 29, 68, 10.1038/nbt.1732 · DOI
  26. Stroud, 2011, 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells, Genome Biol., 12, R54, 10.1186/gb-2011-12-6-r54 · DOI
  27. Vasanthakumar, 2013, Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis, Blood, 121, 2059, 10.1182/blood-2012-04-421065 · DOI
  28. Vicent, 2010, Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models, J. Clin. Invest., 120, 3940, 10.1172/JCI44165 · DOI
  29. Wang, 1993, A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1, Proc. Natl. Acad. Sci. USA, 90, 8896, 10.1073/pnas.90.19.8896 · DOI
  30. Wang, 2009, Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger, Nature, 459, 847, 10.1038/nature08036 · DOI
  31. Yan, 2011, Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia, Nat. Genet., 43, 309, 10.1038/ng.788 · DOI
  32. Yu, 2012, Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome, Cell, 149, 1368, 10.1016/j.cell.2012.04.027 · DOI
  33. Zhan, 1998, Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding, Mol. Cell. Biol., 18, 2768, 10.1128/MCB.18.5.2768 · DOI
  34. Zuber, 2011, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature, 478, 524, 10.1038/nature10334 · DOI · Paper page

Cited by

See all 261

Metadata

Authors
Rampal, R., Alkalin, A., Madzo, J., Vasanthakumar, A., Pronier, E., Patel, J., Li, Y., Ahn, J., Abdel-Wahab, O., Shih, A., Lu, C., Ward, P. S., Tsai, J. J., Hricik, T., Tosello, V., Tallman, J. E., Zhao, X., Daniels, D., Dai, Q., Ciminio, L., Aifantis, I., He, C., Fuks, F., Tallman, M. S., Ferrando, A., Nimer, S., Paietta, E., Thompson, C. B., Licht, J. D., Mason, C. E., Godley, L. A., Melnick, A., Figueroa, M. E., & Levine, R. L.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2014-12
Volume
9
Issue
5
Pages
1841-1855
ISSN
2211-1247
DOI
10.1016/j.celrep.2014.11.004
PMC
PMC4267494
Cited by
261
References
8
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review